CTAS
59
4
NUE
58
7
ROST
52
5
ICE
62
3
HBI
55
-4
F
47
4
RIG
58
4
AA
60
9
KMI
69
2
FDX
40
4
ORCL
67
2
CMS
60
2
NWL
50
6
ESS
64
4
DE
56
10
KR
38
4
HPE
61
6
SBUX
39
3
EQIX
62
2
TMO
47
3
CTAS
59
4
NUE
58
7
ROST
52
5
ICE
62
3
HBI
55
-4
F
47
4
RIG
58
4
AA
60
9
KMI
69
2
FDX
40
4
ORCL
67
2
CMS
60
2
NWL
50
6
ESS
64
4
DE
56
10
KR
38
4
HPE
61
6
SBUX
39
3
EQIX
62
2
TMO
47
3
Financhill
Back

Pharming Group Vs. ProQR Therapeutics NV Industry Stock Comparison

Sell
42

PHAR
Pharming Group

Last Price:
7.48
Seasonality Move:
13.41%
Buy
51

PRQR
ProQR Therapeutics NV

Last Price:
3.63
Seasonality Move:
18.99%
Sell
42
Pharming Group (PHAR) is a Sell

Is Pharming Group a Buy, Sell or Hold?

  • The current Pharming Group [PHAR] share price is $7.76. The Score for PHAR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • PHAR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
ProQR Therapeutics NV (PRQR) is a Buy

Is ProQR Therapeutics NV a Buy, Sell or Hold?

  • The current ProQR Therapeutics NV [PRQR] share price is $3.61. The Score for PRQR is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • PRQR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

PHAR Stock Price Chart

What is Pharming Group's stock price today?

  • The Pharming Group share price today is $7.76
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PHAR is experiencing buying pressure, which is a positive indicator for future bullish movement.

PRQR Stock Price Chart

What is ProQR Therapeutics NV's stock price today?

  • The ProQR Therapeutics NV share price today is $3.61
    The current trend is moderately bullish and PRQR is experiencing selling pressure, which indicates risk of future bearish movement.

PHAR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.19 Sell
Relative Strength Index (14 RSI): 42.78 Sell
Chaikin Money Flow: 10574 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.88 - 8.8) Sell
Bollinger Bands (100): (7.59 - 8.61) Sell

PRQR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.23 Buy
Relative Strength Index (14 RSI): 54.31 Buy
Chaikin Money Flow: -146694 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.47 - 3.93) Sell
Bollinger Bands (100): (1.54 - 3.18) Buy

PHAR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.86 Sell
20-day SMA: 8.21 Sell
50-day SMA: 8.25 Sell
200-day SMA: 9.11 Sell
8-day EMA: 7.85 Sell
20-day EMA: 8.09 Sell
50-day EMA: 8.19 Sell
200-day EMA: 9.02 Sell

PRQR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.78 Sell
20-day SMA: 3.68 Sell
50-day SMA: 2.81 Buy
200-day SMA: 2.18 Buy
8-day EMA: 3.7 Sell
20-day EMA: 3.58 Buy
50-day EMA: 3.06 Buy
200-day EMA: 2.31 Buy

Pharming Group Earnings Growth & PHAR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.01 per share, and an increase next year of $0.03 per share.

ProQR Therapeutics NV Earnings Growth & PRQR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.06 per share.

Pharming Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

ProQR Therapeutics NV Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):